Our Team
Justin Xiang, PhD
Chief Investment Officer & Co-founder
Dr. Xiang is the Chief Investment Officer and Co-Founder of Syno Capital, a global healthcare and biotech investment firm based in New York City that emphasizes on cross-border collaborations between United States and China. In addition, Dr. Xiang is a senior advisor to ZhongAn Insurance, a pioneer online insurance platform in China jointly founded by Alibaba, Tencent and Ping An Insurance. Dr. Xiang is also a member of the International Advisory Council of the Massachusetts General Hospital and advises the hospital on its global initiatives. Dr. Xiang has served on the board of numerous biotech, diagnostic and healthcare companies, and has co-founded and managed several companies including the healthcare services subsidiary of ZhongAn and an oral care joint-venture with Colgate-Palmolive.
Prior to his current roles, Dr. Xiang served as a Senior Scientist at Schrodinger Inc., a leading NASDAQ-listed software and drug development firm backed by industry leaders including David E. Shaw and Bill Gates that specializes in computer-aided drug design. He was responsible for developing next-generation computational tools for rational drug design and various other client drug development programs. Previously, Dr. Xiang was also part of Genentech’s Medicinal Chemistry team, where he participated in numerous lead drug candidate optimization projects.
Dr. Xiang holds a doctoral degree in Molecular Biophysics from Washington University Medical School. His research focus was the development of cutting-edge computational models to optimize the drug design process. Dr. Xiang authored several publications on this topic in internationally recognized peer-reviewed journals, including Journal of Computational Chemistry and Journal of Chemical Theory and Computation. He graduated Magna Cum Laude from Washington University in St. Louis with bachelor’s degrees in Biomedical Engineering, Economics, Mathematics and Computer Science.
Joseph Weilgus, CPA
Managing Director & Co-founder
Mr. Weilgus founded Syno Capital with Dr. Justin Xiang. Mr. Weilgus currently serves as Chief Executive Officer of the New Legacy Group of Companies, a group of finance and investment businesses.
Mr. Weilgus was President of Geller Holdings, LLC and Managing Director, Client Relations at Geller & Co. Prior to joining Geller, Mr. Weilgus was Director of Client Relations at American Express Tax and Business Services. Before joining American Express he was a Senior Associate with PricewaterhouseCoopers in the audit practice where he earned his CPA.
Mr. Weilgus is Founder and Chairman of Project Sunshine, a multi-national children's non-profit organization. Mr. Weilgus founded Project Sunshine out of his college dorm room in 1998. Its 18,000 volunteers now serve over 175,000 children a year in 175 cities across the U.S., Canada, Africa, China and the Middle East.
Mr. Weilgus earned a B.S. in Accounting from Yeshiva University. He is the Founder and Chairman of the Board of Project Sunshine and an active member of the Young Presidents Organization.
Jake Rhyner
Analyst
Jake joined Syno Capital in 2024. He is responsible for investment research, due diligence, and firm operations. Previously, he has experience at multiple early-stage startups ranging from pre-seed to Series B, in healthcare, medical device, and enterprise software. There, his work involved creating and scaling GTM processes, developing marketing strategies, and directly supporting fundraising activities.
Jake graduated from the University of Washington where he majored in finance with a minor in Spanish language.
